Canada Markets open in 9 hrs 13 mins

ZIVO Bioscience, Inc. (ZIVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8000+0.0300 (+1.08%)
At close: 04:00PM EST
2.8000 0.00 (0.00%)
After hours: 07:24PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.7700
Open2.8300
Bid2.5100 x 1000
Ask2.8500 x 3000
Day's Range2.6800 - 2.8300
52 Week Range0.1000 - 7.9000
Volume16,838
Avg. Volume105,458
Market Cap26.375M
Beta (5Y Monthly)0.11
PE Ratio (TTM)N/A
EPS (TTM)-1.2100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
  • Business Wire

    ZIVO Bioscience Names Chairman John B. Payne as President and CEO

    KEEGO HARBOR, Mich., January 10, 2022--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) ("ZIVO" or the "Company"), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces that Chairman of the Board John B. Payne has been named President and Chief Executive Officer of the Company. Mr. Payne succeeds Andrew A. Dahl.

  • GlobeNewswire

    Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT

    KEEGO HARBOR, Mich., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, announced today that Company CEO Andrew A. Dahl has been invited to present at the Global AgTech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on October 14,

  • GlobeNewswire

    Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.

    KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, today issues a notice to its shareholders concerning the annual shareholder meeting. Pursuant to the Notice previously provided for the Annual Meeting of Shareholders of Zivo Bioscie